Crossmark

B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection

Published Online: 2023-07-01

Published Print: 2023-09

Authors

Cremer, Jennifer

Elston, Robert

Campbell, Fiona M.

Kendrick, Stuart

Paff, Melanie

Quinn, Geoff

Theodore, Dickens
Funding

Funding for this research was provided by:

GSK (209668)
License Information

Text and Data Mining valid from 2023-07-01

Version of Record valid from 2023-07-01
More Information

Article History

Received: 31 January 2023

Accepted: 25 April 2023

First Online: 1 July 2023

Document is current